Advanced Accelerator Applications S.A. EBIT Margin

EBIT Margin of AAAP for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT Margin growth rates and interactive chart. Earnings before interest and taxes margin is an indicator of a company's profitability. Calculated as earnings before interest and taxes (EBIT) divided by revenue. It is useful for comparison of companies with different debt levels and tax rates. And EBIT margin gives a clear picture about the underlying profitability of a company's core operations. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes.


Highlights and Quick Summary

  • EBIT Margin for the quarter ending September 29, 2017 was -9.9% (a -39.49% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT Margin decreased by -77.84%
  • Annual EBIT Margin for 2016 was -17.83% (a 65.71% increase from previous year)
  • Annual EBIT Margin for 2015 was -10.76% (a -12.59% decrease from previous year)
  • Twelve month EBIT Margin ending September 29, 2017 was -21.04% (a -13.24% decrease compared to previous quarter)
  • Twelve month trailing EBIT Margin increased by 18.0% year-over-year
Trailing EBIT Margin for the last four month:
29 Sep '17 29 Jun '17 30 Mar '17 30 Dec '16
-21.04% -24.25% -21.62% -17.83%
Visit stockrow.com/AAAP for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT Margin of Advanced Accelerator Applications S.A.

Most recent EBIT Marginof AAAP including historical data for past 10 years.

Interactive Chart of EBIT Margin of Advanced Accelerator Applications S.A.

Advanced Accelerator Applications S.A. EBIT Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2017 -9.9% -16.36% -19.9%
2016 -44.68% -19.25% -3.48% -4.16% -17.83%
2015 -2.65% -10.76%
2014 -12.31%

Business Profile of Advanced Accelerator Applications S.A.

Sector: Medical
Industry: Drugs